Descripción de la empresa
Above Food Ingredients Inc. operates as a regenerative ingredient company that produces vertically integrated supply chain products across a global network spanning Canada, the United States, Mexico, China, France, Turkey, and international markets. The entity functions within the Consumer Defensive sector, specifically inside the Packaged Foods industry, a classification that suggests a focus on staple goods where demand tends to be relatively inelastic regardless of economic cycles. The company's market capitalization stands at $43.77M, with reported annual revenue (TTM) of $294.84M, while the specific count of employees is not disclosed in available data. These valuation and revenue figures indicate that Above Food Ingredients Inc. maintains a small-cap profile, positioning it as a niche player rather than a dominant force in the broader packaged foods landscape. The combination of a modest market cap and substantial revenue turnover suggests the company may be operating with significant scale in its production capabilities despite its limited valuation relative to larger peers in the defensive sector.
Salud financiera
The company reported a revenue of $294.84M for the trailing twelve months, yet this top-line performance is accompanied by a net income of $-61,292,864 and an EBITDA of $-40,343,004, revealing a severe disconnect between sales generation and profitability. The substantial gap between the positive revenue figure and the deeply negative net income highlights a cost structure where operating expenses and the cost of goods sold far exceed the revenue generated, resulting in a loss-making operation. Free cash flow metrics are not available for reporting, which implies that the company's operational cash generation is either negligible or insufficient to cover capital expenditures without external financing, thereby limiting its financial flexibility. Analyzing the three key margins shows a gross margin of -2.8%, an operating margin of -23.3%, and a profit margin of -23.4%, indicating that the company struggles to cover its variable costs before operating expenses and loses money on every unit sold. The balance sheet presents a highly leveraged profile with total debt of $133.84M compared to a cash balance of only $664,430, while the debt-to-equity ratio is not disclosed. This disparity between liabilities and liquid assets suggests the company is heavily reliant on external debt servicing rather than internal cash reserves. Furthermore, a current ratio of 0.23 indicates a critical liquidity shortfall, meaning the company holds less than a quarter of the assets required to cover its short-term obligations. Return on Equity and Return on Assets are both unavailable, which precludes an assessment of management effectiveness in generating returns on the capital base.
Evaluación de valoración
Trailing P/E and forward P/E ratios are not available due to the company's lack of profitability, preventing a standard earnings-based valuation comparison with peers. The price-to-book ratio stands at -2.01, a negative figure that indicates the market values the company at a discount below its net book value, often seen in distressed or loss-making entities. Alternative valuation metrics such as the price-to-sales ratio of 0.15 and an EV/EBITDA of -3.91 suggest that investors are pricing the stock based on minimal revenue multiples rather than earnings power. The stock has traded between a 52-week low of $0.32 and a 52-week high of $6.56, and without a specific current price provided in the facts, the precise percentage deviation from these bounds cannot be calculated, though the wide range demonstrates extreme price instability. The beta value is recorded at 0.13, indicating that the stock exhibits very low volatility relative to the broader market, moving significantly less than the S&P 500 index. This low beta suggests the stock price is largely decoupled from general market sentiment, which is characteristic of small-cap or micro-cap stocks with limited trading volume and specific idiosyncratic risks.
Growth & Income
The revenue growth year-over-year is -45.0%, while earnings growth is not available, indicating a sharp contraction in sales volume that has directly contributed to the company's losses. Since earnings are negative, there is no growth trajectory to compare against revenue, but the decline in revenue itself implies a contraction in the company's market share or pricing power within its segments. As a non-dividend payer, the company does not distribute cash to shareholders, evidenced by a dividend yield of N/A and a payout ratio of 0.0%. Consequently, the company reinvests its minimal or negative earnings back into operations, though the negative cash position limits the resources available for such reinvestment. The overall growth and income profile is characterized by significant revenue contraction, negative profitability, and an absence of dividend income, presenting a challenging financial picture for income-oriented or growth-seeking investors.